Drug industry launches pro-health reform advertising blitz
Aug 18, 2009
PhRMA has launched a $12 million advertising push for healthcare reform, with TV spots airing in key states and on cable channels nationally. The ads stress the importance of ensuring that patients aren’t...
New forms from Briggs are easier on the eyes
Aug 16, 2011
Briggs Medical Service Company has introduced a new line of easier-to-read forms. These are printed in much larger font size, which makes it easier for providers to fill them out. These “EZtoC”...
Three companies merge to create home care juggernaut
Apr 17, 2018
Three firms announced they will merge to form one of the nation’s largest home care companies.
American HealthTech passes ICD-10 claim test
Apr 22, 2014
American HealthTech has passed the ICD-10 claim test for Medicare Billing 837i and Form CMS-UB04, the company announced.
Discounted hotel rooms available for ACHCA show
Apr 06, 2009
The American College of Health Care Administrators will hold its annual convocation and exposition May 15-19 in Providence, RI. The organization recently announced that it has negotiated discounted group...
Reutlinger Community partners with AFFIRMA Rehabilitation
Aug 05, 2015
The Reutlinger Community in California has formed a strategic partnership with AFFIRMA Rehabilitation, a national rehabilitation therapy services provider.
Credentialing software acquired
Nov 22, 2017
Change Healthcare said Monday it had acquired dental provider credentialing software technology from Docufill LLC.
Partnership with Gift of Life Marrow Registry formed
Aug 01, 2018
HJ Sims has announced the debut of its Sims’ Corporate Social Responsibility program and a partnership with the Gift of Life Marrow Registry.
Electronic form manager eases signature requirements
Aug 03, 2011
IVANS eFormManager is an electronic signature application that replaces the time-consuming task of mailing in or faxing a CMS Form 485 and Face-to-Face documentation. The product also can be used with...
Phase III trials of Alzheimer’s drug are halted
Aug 14, 2012
The tests, for the drug bapineuzumab, are being stopped after the drug failed to hit its goals for cognition and global function.